Antibiotic prescribing and expenditures in outpatient paediatrics in Greece, 2010-13

Georgia Kourlaba1, Eleni Kourkouni2, Nikos Spyridis3

  • 1The Stavros Niarchos Foundation - Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), University of Athens School of Medicine, Athens, Greece kurlaba@gmail.com.

Insights

Over 7 million antibiotics were prescribed to children in Greece, with most being broad-spectrum for respiratory infections. This highlights a need for antimicrobial stewardship programs in pediatric outpatient care.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Pharmacoeconomics

Background:

  • Antibiotic prescribing patterns in pediatric outpatient settings are not well-characterized nationally.
  • Understanding antibiotic use and costs is crucial for developing effective antimicrobial stewardship.

Purpose of the Study:

  • To analyze antibiotic prescribing trends in Greek outpatient pediatrics.
  • To determine the economic impact of antibiotic prescriptions in this population.

Main Methods:

  • Utilized IMS Health Xponent database for prescriptions in patients aged ≤19 years (July 2010-June 2013).
  • Calculated prescribing rates using prescription numbers and census data.
  • Assessed total expenditures for prescribed antibiotics.

Main Results:

  • Over 7 million antibiotics were prescribed, with an annual rate of 1100/1000 persons.
  • Acute respiratory tract infections (ARTIs) were the primary indication (80%), particularly acute otitis media and tonsillitis.
  • Broad-spectrum antibiotics constituted 90.4% of prescriptions, with expenditures reaching ~€50 million.

Conclusions:

  • Broad-spectrum antibiotic use is prevalent in Greek pediatric outpatient care.
  • Findings identify key areas for antimicrobial stewardship interventions targeting specific conditions and practices.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
838
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
360
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
505
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K